NASDAQ:VRTX   Vertex Pharmaceuticals Incorporated
125% earnings growth past quarter, +30% previous quarters
+76% revenue growth past quarter, accelerating from the precious quarters
Positive earnings revisions

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.